Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure
Prescription drug use is prevalent during pregnancy, yet there is limited knowledge about maternal-fetal safety and efficacy of this drug use because pregnant individuals have historically been excluded from clinical trials. Underrepresentation has resulted in a lack of data available to estimate or...
Main Authors: | Rachel E. Hudson, Torri D. Metz, Robert M. Ward, Autumn M. McKnite, Elena Y. Enioutina, Catherine M. Sherwin, Kevin M. Watt, Kathleen M. Job |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1111601/full |
Similar Items
-
Obstetric pharmacokinetic dosing studies are urgently needed
by: Shelley A. McCormack, et al.
Published: (2014-02-01) -
Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models
by: Nupur Chaphekar, et al.
Published: (2021-11-01) -
An interaction between fetal sex and placental weight and efficiency predicts intrauterine growth in response to maternal protein insufficiency and gestational exposure window in a mouse model of FASD
by: Sze Ting Cecilia Kwan, et al.
Published: (2020-07-01) -
Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine
by: Lixia He, et al.
Published: (2022-11-01) -
Alcohol exposure before and during pregnancy is associated with reduced fetal growth: the Safe Passage Study
by: Marin Pielage, et al.
Published: (2023-08-01)